ArticleCureus2026
Pediatric Enterovirus Encephalitis: Clinical, Neuroimaging, and Prognostic Insights From a Single-Center Study in the UAE.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enteroviral encephalitis in children is rare but can lead to severe neurological complications. This study describes the clinical, neuroimaging, and laboratory features of pediatric enteroviral encephalitis at Burjeel Hospital, Abu Dhabi, and explores, in an exploratory and hypothesis-generating manner, associations between clinical findings, laboratory results, neuroimaging, and patient outcomes. This is a small descriptive case series (n = 9), and all findings should be interpreted accordingly. A retrospective study included nine pediatric patients with enteroviral encephalitis confirmed by CSF PCR; other etiologies were excluded per predefined inclusion and exclusion criteria. The median age was five years, with a male predominance (n = 7; 77.8%). Symptoms included fever (9/9; 100%), vomiting (8/9; 88.9%), headache (7/9; 77.8%), and neck stiffness (7/9; 77.8%). Seizures occurred in one patient (1/9; 11.1%). Total hospital stays ranged from 2 to 15 days (median three days); PICU stays ranged from 1 to 12 days (median one day). As an exploratory observation, neuroimaging abnormalities showed an association with prolonged PICU stays (rs = 0.694, p = 0.038) and adverse outcomes, while CRP levels did not (rs =- 0.548, p = 0.127); these are hypothesis-generating findings only and not confirmatory. One patient (1/9; 11.1%) with ALERD on MRI had the most severe outcome, including long-term neurological sequelae. Eight of nine patients (8/9; 88.9%) achieved full neurological recovery with supportive care alone. This exploratory case series suggests a potential role for early neuroimaging in clinical decision-making and contributes region-specific data from the UAE. Prospective multicenter studies are required to validate these observations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.